These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 19487896

  • 1. Dose-related efficacy of a continuous intracisternal nimodipine treatment on cerebral vasospasm in the rat double subarachnoid hemorrhage model.
    Hänggi D, Eicker S, Beseoglu K, Rapp M, Perrin J, Nawatny J, Turowski B, Sommer C, Steiger HJ.
    Neurosurgery; 2009 Jun; 64(6):1155-9; discussion 1159-61. PubMed ID: 19487896
    [Abstract] [Full Text] [Related]

  • 2. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
    Hänggi D, Beseoglu K, Turowski B, Steiger HJ.
    Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
    [Abstract] [Full Text] [Related]

  • 3. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm.
    Hänggi D, Eicker S, Beseoglu K, Behr J, Turowski B, Steiger HJ.
    Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257
    [Abstract] [Full Text] [Related]

  • 4. Effects of ebselen versus nimodipine on cerebral vasospasm subsequent to experimental subarachnoid hemorrhage in rats.
    Gul S, Bahadir B, Hanci V, Acikgoz S, Bektas S, Ugurbas E, Ankarali H, Kalayci M, Acikgoz B.
    J Clin Neurosci; 2010 May; 17(5):608-11. PubMed ID: 20188570
    [Abstract] [Full Text] [Related]

  • 5. Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage.
    Atalay B, Caner H, Cekinmez M, Ozen O, Celasun B, Altinors N.
    Neurosurgery; 2006 Nov; 59(5):1102-7; discussion 1107-8. PubMed ID: 17143244
    [Abstract] [Full Text] [Related]

  • 6. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R, Kunz M, Zausinger S, Prueckner S, Briegel J, Steiger HJ.
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [Abstract] [Full Text] [Related]

  • 7. Admission angiographic cerebral circulation time may predict subsequent angiographic vasospasm after aneurysmal subarachnoid hemorrhage.
    Udoetuk JD, Stiefel MF, Hurst RW, Weigele JB, LeRoux PD.
    Neurosurgery; 2007 Dec; 61(6):1152-9; discussion 1159-61. PubMed ID: 18162893
    [Abstract] [Full Text] [Related]

  • 8. Resistant vasospasm in subarachnoid hemorrhage treated with continuous intraarterial nimodipine infusion.
    Doukas A, Petridis AK, Barth H, Jansen O, Maslehaty H, Mehdorn HM.
    Acta Neurochir Suppl; 2011 Dec; 112():93-6. PubMed ID: 21691994
    [Abstract] [Full Text] [Related]

  • 9. 17beta-estradiol inhibits endothelin-1 production and attenuates cerebral vasospasm after experimental subarachnoid hemorrhage.
    Lin CL, Dumont AS, Wu SC, Wang CJ, Howng SL, Huang YF, Wong WY, Kassell NF, Jeng AY, Kwan AL.
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1054-7. PubMed ID: 16741048
    [Abstract] [Full Text] [Related]

  • 10. Continuous local intra-arterial nimodipine administration in severe symptomatic vasospasm after subarachnoid hemorrhage.
    Musahl C, Henkes H, Vajda Z, Coburger J, Hopf N.
    Neurosurgery; 2011 Jun; 68(6):1541-7; discussion 1547. PubMed ID: 21311378
    [Abstract] [Full Text] [Related]

  • 11. Time course in the development of cerebral vasospasm after experimental subarachnoid hemorrhage: clinical and neuroradiological assessment of the rat double hemorrhage model.
    Vatter H, Weidauer S, Konczalla J, Dettmann E, Zimmermann M, Raabe A, Preibisch C, Zanella FE, Seifert V.
    Neurosurgery; 2006 Jun; 58(6):1190-7; discussion 1190-7. PubMed ID: 16723899
    [Abstract] [Full Text] [Related]

  • 12. Local delivery of nimodipine by prolonged-release microparticles-feasibility, effectiveness and dose-finding in experimental subarachnoid hemorrhage.
    Hänggi D, Perrin J, Eicker S, Beseoglu K, Etminan N, Kamp MA, Heiroth HJ, Bege N, Macht S, Frauenknecht K, Sommer C, Kissel T, Steiger HJ.
    PLoS One; 2012 Jun; 7(9):e42597. PubMed ID: 23049732
    [Abstract] [Full Text] [Related]

  • 13. Effect of intraarterial papaverine or nimodipine on vessel diameter in patients with cerebral vasospasm after subarachnoid hemorrhage.
    Kerz T, Boor S, Beyer C, Welschehold S, Schuessler A, Oertel J.
    Br J Neurosurg; 2012 Aug; 26(4):517-24. PubMed ID: 22303863
    [Abstract] [Full Text] [Related]

  • 14. The effects of intravenous cilostazol and nimodipine on cerebral vasospasm after subarachnoid hemorrhage in an experimental rabbit model.
    Bilginer B, Onal MB, Narin F, Soylemezoglu F, Ziyal IM, Ozgen T.
    Turk Neurosurg; 2009 Oct; 19(4):374-9. PubMed ID: 19847758
    [Abstract] [Full Text] [Related]

  • 15. Effect of vasodilation by milrinone, a phosphodiesterase III inhibitor, on vasospastic arteries after a subarachnoid hemorrhage in vitro and in vivo: effectiveness of cisternal injection of milrinone.
    Nishiguchi M, Ono S, Iseda K, Manabe H, Hishikawa T, Date I.
    Neurosurgery; 2010 Jan; 66(1):158-64; discussion 164. PubMed ID: 20023546
    [Abstract] [Full Text] [Related]

  • 16. Intraarterial nimodipine for the treatment of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a preliminary study.
    Dehdashti AR, Binaghi S, Uske A, Regli L.
    Neurol India; 2011 Jan; 59(6):810-6. PubMed ID: 22234190
    [Abstract] [Full Text] [Related]

  • 17. The effects of clenbuterol on cerebral vasospasm in an experimental rat model of subarachnoid hemorrhage.
    Benek B, Acar F, Cirak B, Coskun E, Ozcakar L, Yalcin N, Suzer T, Tahta K.
    Acta Neurol Belg; 2011 Sep; 111(3):201-4. PubMed ID: 22141283
    [Abstract] [Full Text] [Related]

  • 18. Continuous intra-arterial infusion of nimodipine at the onset of resistant vasospasm in aneurysmal subarachnoidal haemorrhage. Technical report.
    Doukas A, Petridis AK, Barth H, Jansen O, Mehdorn HM.
    Neurol Res; 2011 Apr; 33(3):290-4. PubMed ID: 20626962
    [Abstract] [Full Text] [Related]

  • 19. Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results.
    Bele S, Proescholdt MA, Hochreiter A, Schuierer G, Scheitzach J, Wendl C, Kieninger M, Schneiker A, Bründl E, Schödel P, Schebesch KM, Brawanski A.
    Acta Neurochir (Wien); 2015 Dec; 157(12):2041-50. PubMed ID: 26439105
    [Abstract] [Full Text] [Related]

  • 20. The effects of dexmedetomidine dosage on cerebral vasospasm in a rat subarachnoid haemorrhage model.
    Ayoglu H, Gul S, Hanci V, Bahadir B, Bektas S, Mungan AG, Turan IO, Acikgoz B.
    J Clin Neurosci; 2010 Jun; 17(6):770-3. PubMed ID: 20381357
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.